Corona Remedies Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Crore)
Corona Remedies Ltd · Outcome · 30 Oct 2026, 11:58 pm
Corona Remedies Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Crore) ■ Revenue: 441 (+22.2% YoY | +4.4% QoQ) ■ EBITDA: 96.0 (+22.3% YoY | +3.0% QoQ) ■ EBITDA Margin (%): 21.7 (+2 bps YoY | -30 bps QoQ) ■ PAT: 60.3 (+15.3% YoY | +0.3% QoQ) ■ EPS (INR): 9.86 (+15.3% YoY | +0.3% QoQ)
Original exchange filing (PDF)
More announcements from Corona Remedies Ltd
- Intimation of Participation in Analyst / Investor Conference · 16 Nov 2026
- Intimation of Participation in Analyst / Investor Conference · 07 Nov 2026
- Transcript of Earnings Call with Analyst / Investor on Unaudited Financial Results for the second quarter and half year ended September 30, 2026 · 05 Nov 2026
- Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015 · 04 Nov 2026
- Audio Recording of Q2H1FY27 Earnings Conference Call with Analysts / Investors · 02 Nov 2026
- Intimation for Analyst / Investor Meet · 31 Oct 2026
- Analyst / Investor Presentation · 31 Oct 2026
- Press Release on Financial Results for second quarter and half year ended on September 30, 2026 · 31 Oct 2026
